Cooper-Standard Holdings Inc. — Form 10-Q Summary
Period clarification: The request metadata says 2011 Q1, but the supplied filing is for the quarter ended March 31, 2012, with comparison to Q1 2011. The financial statements are unaudited; dollar figures below are in millions unless noted.
Business context and reporting period
Cooper-Standard manufactures fluid-handling, body-sealing and anti-vibration products, primarily for automotive OEMs and replacement markets. It reports North America and International segments.
Financial performance and liquidity
| Metric | Q1 2011 | Q1 2012 |
|---|---|---|
| Sales | $688.8 | $765.3 |
| Gross profit / margin | $120.8 / 17.5% | $121.7 / 15.9% |
| Operating profit / margin | $51.4 / 7.5% | $39.7 / 5.2% |
| Net income attributable to Cooper-Standard | $44.9 | $23.8 |
| Basic / diluted EPS | $1.97 / $1.78 | $0.97 / $0.90 |
| Net cash from operating activities | $(21.6) | $(34.6) |
- Sales grew 11.1%, but cost of products sold rose 13.3%; gross profit was nearly flat. Higher material, commodity and labor costs weighed on margins. Selling, administration and engineering expense increased to $72.0 million from $60.9 million; restructuring expense rose to $6.1 million from $4.6 million.
- Q1 2011 other income included an $11.4 million gain on a partial joint-venture sale; its absence in 2012 contributed to lower pretax and net income. Net interest expense increased to $11.2 million from $9.9 million.
- Cash and equivalents were $296.0 million at March 31, down $65.8 million from year-end. Current assets were $1,058.5 million and current liabilities $524.8 million (current ratio approximately 2.0). Operating cash use included $95.8 million from changes in operating assets and liabilities, mainly receivables and inventories.
- Total debt was $491.1 million, including $37.2 million due within one year; senior notes were $450.0 million. No borrowings were outstanding under the $125 million Senior ABL Facility, subject to borrowing-base availability; letters of credit outstanding were about $28.6 million.
- Capital expenditures were $29.2 million. The company reported $83.2 million of Adjusted EBITDA versus $91.9 million in Q1 2011; this is a non-GAAP measure and should not be treated as a substitute for GAAP earnings or operating cash flow.
Changes versus the prior comparable period
- Sales gains reflected higher U.S. volumes, the USi acquisition and the FMEA joint venture, which together contributed $57.7 million of sales in Q1 2012; unfavorable foreign exchange reduced sales by $17.5 million.
- North America segment sales increased 8.2% to $388.1 million, but segment profit fell to $38.0 million from $54.3 million. International sales rose 14.3% to $377.1 million, while the segment moved to a $5.8 million loss from $3.3 million profit.
- Cash used in operations increased from $21.6 million to $34.6 million, and investing cash use increased from $6.2 million to $26.6 million, largely reflecting higher capital spending and different acquisition/disposal activity.
Outlook, commentary and risks
- Management expected 2012 capital expenditures of approximately $110–$120 million and said cash, operating cash flow, receivables factoring and available ABL capacity should fund requirements for the next 12 months and foreseeable future. That assessment depends on future performance, cash flow, borrowing-base limits and covenant compliance.
- Management cited IHS Automotive estimates of 2012 light-vehicle production of 14.6 million units in North America and 18.8 million in Europe. Q1 production was up approximately 15.2% in North America and down 7.5% in Europe year over year.
- A March 2012 explosion at a German chemical supplier disrupted production of PA-12, used in automotive fuel and brake components. The supplier represented 35% of global PA-12 output; the company was working on alternative materials, but warned of possible production interruptions and material adverse effects.
- Other stated risks include automotive demand and customer concentration, price and raw-material pressures, foreign exchange, labor costs, restructuring execution, joint-venture performance, debt and cash-generation needs, pension obligations, litigation and environmental matters. The company said ordinary-course legal and environmental matters were not expected to have a material adverse effect.
- The company disclosed that a release of U.S. deferred-tax valuation allowances could possibly occur during 2012; any release would materially affect earnings in the period recorded. No specific earnings or revenue guidance was provided.
Important facts for investors to verify
- Confirm the reporting-period mismatch: this filing covers Q1 2012, not Q1 2011.
- Track whether margin pressure, particularly in International operations, improves despite sales growth and lean-savings efforts.
- Assess working-capital cash consumption, planned $110–$120 million capital spending, and the company’s ability to sustain liquidity and meet debt obligations.
- Monitor PA-12 supply disruption, alternative-material approvals and any resulting customer production interruptions.
- Review restructuring costs and remaining commitments, tax valuation-allowance judgments, factoring arrangements and ABL borrowing-base/covenant capacity.